LL-37 Immunomodulatory Activity during Mycobacterium tuberculosis Infection in Macrophages

Infection and Immunity
Flor Torres-JuarezBruno Rivas-Santiago

Abstract

Tuberculosis is one of the most important infectious diseases worldwide. The susceptibility to this disease depends to a great extent on the innate immune response against mycobacteria. Host defense peptides (HDP) are one of the first barriers to counteract infection. Cathelicidin (LL-37) is an HDP that has many immunomodulatory effects besides its weak antimicrobial activity. Despite advances in the study of the innate immune response in tuberculosis, the immunological role of LL-37 during M. tuberculosis infection has not been clarified. Monocyte-derived macrophages were infected with M. tuberculosis strain H37Rv and then treated with 1, 5, or 15 μg/ml of exogenous LL-37 for 4, 8, and 24 h. Exogenous LL-37 decreased tumor necrosis factor alpha (TNF-α) and interleukin-17 (IL-17) while inducing anti-inflammatory IL-10 and transforming growth factor β (TGF-β) production. Interestingly, the decreased production of anti-inflammatory cytokines did not reduce antimycobacterial activity. These results are consistent with the concept that LL-37 can modulate the expression of cytokines during mycobacterial infection and this activity was independent of the P2X7 receptor. Thus, LL-37 modulates the response of macrophages during infectio...Continue Reading

References

Nov 1, 1991·The Journal of Clinical Investigation·W P Arend
Oct 30, 1999·The European Respiratory Journal·T C TsaoK S Chang
Feb 16, 2002·Methods : a Companion to Methods in Enzymology·K J Livak, T D Schmittgen
Jun 6, 2002·Immunology·Javier Rangel MorenoRogelio Hernández Pando
Apr 7, 2004·The Journal of Immunology : Official Journal of the American Association of Immunologists·Andreas ElssnerMark D Wewers
Dec 20, 2005·The Journal of Pathology·Timo Ulrichs, Stefan H E Kaufmann
Jan 24, 2006·Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research·Sherry FreemanGilla Kaplan
Feb 4, 2006·The Journal of Immunology : Official Journal of the American Association of Immunologists·Neeloffer MookherjeeRobert E W Hancock
Aug 10, 2006·The Journal of Infectious Diseases·Bruno Rivas-SantiagoRogelio Hernandez-Pando
Aug 7, 2007·The Journal of Immunology : Official Journal of the American Association of Immunologists·Philip T LiuRobert L Modlin
Nov 21, 2007·The Journal of Immunology : Official Journal of the American Association of Immunologists·Jie YuRobert E W Hancock
Apr 22, 2009·Molecular BioSystems·Neeloffer MookherjeeRobert E W Hancock
Oct 9, 2009·The Journal of Immunology : Official Journal of the American Association of Immunologists·Anastasia NijnikRobert E W Hancock
Jul 9, 2010·The Journal of Immunology : Official Journal of the American Association of Immunologists·Anne M van der DoesPeter H Nibbering
Mar 29, 2011·The Journal of Immunology : Official Journal of the American Association of Immunologists·Kelly L BrownPauline Johnson
Jun 21, 2011·Frontiers in Microbiology·Smitha J Sasindran, Jordi B Torrelles
Jun 29, 2012·Journal of Innate Immunity·Ka-Yee ChoiNeeloffer Mookherjee
Sep 10, 2013·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Luiz Anastacio AlvesValber da Silva Frutuoso
Dec 19, 2013·BioMed Research International·Md Murad Hossain, Mohd-Nor Norazmi

❮ Previous
Next ❯

Citations

Jun 5, 2016·Journal of Controlled Release : Official Journal of the Controlled Release Society·João P SilvaF Miguel Gama
Jul 8, 2017·Tropical Medicine & International Health : TM & IH·Hoang van TongChristian G Meyer
Aug 5, 2017·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Tânia Silva, Maria Salomé Gomes
Oct 18, 2019·The Journal of Immunology : Official Journal of the American Association of Immunologists·Avinash PadhiAvinash Sonawane
Oct 22, 2019·Clinical and Experimental Immunology·C E Valdez-MiramontesB Rivas-Santiago
Mar 4, 2020·Current Topics in Medicinal Chemistry·Jiarui LiEster Boix
Aug 31, 2020·International Journal of Mycobacteriology·Jalaledin GhanaviAli Akbar Velayati
Jul 5, 2018·Journal of Translational Medicine·Gandharva NagpalGajendra P S Raghava
Dec 28, 2019·International Journal of Molecular Sciences·Suhanya V PrasadRobert Bucki
Nov 23, 2017·Frontiers in Immunology·Javier Arranz-TrullénEster Boix
Sep 1, 2017·Applied Microbiology and Biotechnology·Richa SharmaIndu Verma
May 16, 2020·Frontiers in Cellular and Infection Microbiology·Anuradha RajamanickamSubash Babu
Jun 9, 2020·BioMed Research International·Binbin YangMing Q Wei
Jan 15, 2021·Microbiology and Molecular Biology Reviews : MMBR·Alexandra Y SoareTalia H Swartz
Aug 20, 2016·Acta Microbiologica Et Immunologica Hungarica·Laszlo Otvos
Dec 3, 2020·Tuberculosis·Claudia Valdez MiramontesBruno Rivas-Santiago
May 1, 2021·Pharmaceuticals·Gabriel S OliveiraCátia Teixeira
Aug 10, 2021·Brain, Behavior, and Immunity·Mary-Ellen LynallMenna R Clatworthy
Sep 17, 2021·Archivum Immunologiae Et Therapiae Experimentalis·Bruno Rivas-SantiagoAdrian Rodriguez-Carlos

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anti-inflammatory Treatments

A drug or substance that reduces inflammation (redness, swelling, and pain) in the body. Anti-inflammatory agents block certain substances in the body that cause inflammation and swelling. Discover the latest research on anti-inflammatory treatments here

BCL-2 Family Proteins

BLC-2 family proteins are a group that share the same homologous BH domain. They play many different roles including pro-survival signals, mitochondria-mediated apoptosis and removal or damaged cells. They are often regulated by phosphorylation, affecting their catalytic activity. Here is the latest research on BCL-2 family proteins.

Related Papers

The Journal of Medical Laboratory Technology
B W Allen
Drug Discovery Today. Disease Mechanisms
Matthew Arentz, Thomas R Hawn
Respiratory Physiology & Neurobiology
Leonardo C Monção-RibeiroRobson Coutinho-Silva
© 2021 Meta ULC. All rights reserved